News about Market

NATCO Pharma Acquires Additional 13.25 Percent Stake in Adcock Ingram

NATCO Pharma has completed the acquisition of an additional 13.25 percent stake in South Africa's Adcock Ingram, strengthening its strategic investment in the pharmaceutical company.

Market | 15/07/2026 | By News Bureau |  170

Emcure Takes Full Ownership of Gennova, Strengthens Focus on Biologics and Biosimilars

Emcure Pharmaceuticals has acquired the remaining minority stake in Gennova Biopharmaceuticals, making it a wholly owned subsidiary while appointing Samit Mehta to lead the company’s next phase of growth in biologics and biosimilars.

Market | 14/07/2026 | By News Bureau |  117

Santhera Expands Agamree Distribution Partnership with Biomedica Across Five Additional Markets

Santhera Pharmaceuticals has expanded its exclusive distribution partnership with Biomedica to include Georgia, Kazakhstan, Belarus, Azerbaijan and Uzbekistan, extending access to Agamree (vamorolone) for patients with Duchenne muscular dystrophy across additional underserved markets.

Market | 14/07/2026 | By News Bureau |  113

Torrent Pharma Recalls Select Semalix Injection Batches Following API-Related Quality Issue

Torrent Pharmaceuticals has initiated a recall of select batches of Semalix Injection 2 mg and 4 mg after certain semaglutide batches failed quality specifications due to an API-related issue.

Market | 10/07/2026 | By News Bureau |  261

Novo Nordisk Brings World's First Once-Weekly Basal Insulin Awiqli to India

Novo Nordisk India has launched Awiqli, the world's first once-weekly basal insulin, offering adults with diabetes a more convenient treatment option with fewer injections.

Market | 10/07/2026 | By News Bureau |  288

Evonik Invests USD 100 Million to Expand US Drug Manufacturing

Evonik is investing USD 100 million to upgrade its US drug substance Contract Development and Manufacturing (CDMO) facility, expanding manufacturing capacity to meet growing demand for US-based pharmaceutical outsourcing.

Market | 10/07/2026 | By News Bureau

UK Life Sciences Attracts Investment to Create Jobs and Faster Patient Treatments

The UK life sciences sector has attracted over £3 billion in public-private investment in the past year, accelerating innovation, creating jobs, and improving patient access to new treatments.

Market | 10/07/2026 | By News Bureau

Orchid Pharma Partners with Pharmasyntez to Commercialise Exblifep in Russia

Orchid Pharma has signed an exclusive licensing and supply agreement with Pharmasyntez JSC for Exblifep in Russia. The partnership is expected to strengthen access to advanced antimicrobial therapies while addressing the growing challenge of antibiotic resistance.

Market | 09/07/2026 | By News Bureau |  144

Dr. Reddy's Delays Semaglutide Supplies Following API-Related Quality Issue

Dr. Reddy's Laboratories announces a temporary delay in commercial supplies of semaglutide after identifying an API-related quality issue affecting certain batches. The company is investigating the root cause and has confirmed that patient safety and existing global regulatory filings remain unaffected.

Market | 09/07/2026 | By News Bureau |  102

Vivani Medical and Novo Nordisk Sign Agreement to Evaluate Long-Acting Semaglutide Implant for Weight Management

Vivani Medical has entered into an agreement with Novo Nordisk to evaluate NPM-139, its ultra long-acting semaglutide implant for chronic weight management. The implant aims to offer a convenient once- or twice-yearly treatment option, with Phase 1 clinical trials expected to commence in mid-2026.

Market | 09/07/2026 | By News Bureau